| Application no. and date | 05810600.6 (espacenet) (Federated) (European Patent Register), 20051122 | | Patent/reg. no. and date | DK/EP 1814595, 20140108 | | Publication date | 20070808 | | Priority no. and date | US 522948 P, 20041123, US 522960 P, 20041124 | | EP pub. no. and date |
EP 1814595 20070808 | | Effective date | | | Applicant/owner | THE UNIVERSITY OF BRITISH COLUMBIA, No 103 - 6190 Agronomy Road
Vancouver,
British Columbia V6T 1Z3, CA | | Applicant ref. no. | P013961EPDK1 EJ/GB | | Inventor | GLEAVE, Martin, 4693 Drummond Drive
Vancouver, British Columbia V6R 1E8, CA,
ZUPI, Gabriella, Regina Elena Cancer Institute
Experimental Chemotherapy Lab
Via delle Messi d'Oro, 156
I-00158 Roma, IT | | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | | Opponent | | | IPC Class | A61K 31/7088 (2006.01) , A61K 39/395 (2006.01) , A61K 48/00 (2006.01) , A61P 35/00 (2006.01) | | Title | Behandling af cancer med en kombination af et middel, som forstyrrer EGF-signalvejen og et oligonucleotid, som reducerer clusterinniveauerne | | Int. application no. | CA2005001775 | | Int. publication no. | WO2006056054 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
